Journal article icon

Journal article

Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?

Abstract:

Recent epidemiology attests that hypertriglyceridemia may be a causal risk factor for cardiovascular disease (CVD). The specific atherogenicity of hypertriglyceridemia relates to the accumulation in plasma of triglyceride-rich lipoprotein remnants. Hypertriglyceridemia also drives a 'global' atherogenic dyslipidemic profile, which is frequent in high-risk cardiovascular patients, such as Type 2 diabetics. Elevated triglyceride in fasting or nonfasting blood samples should be a trigger for ass...

Expand abstract

Actions


Access Document


Publisher copy:
10.1586/erc.11.61

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, OCDEM, Biomedical Research Centre
Journal:
Expert review of cardiovascular therapy
Volume:
9
Issue:
8
Pages:
987-997
Publication date:
2011-08-05
DOI:
EISSN:
1744-8344
ISSN:
1477-9072
URN:
uuid:551f202b-f11c-4cbe-a53b-9452244a57ad
Source identifiers:
172129
Local pid:
pubs:172129

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP